Long-term follow-up for vaccines may seem to be a distant concern when clinical trials are just beginning, but it can be critical to have a plan for follow-up at the outset. Learn considerations for follow-up design, s...
From bottlenecks to breakthroughs
Human-centred strategies for faster study starts
Read the whitepaperOptimising vaccine follow-up through early planning
A proactive approach to RWD and tokenisation integration
Read the whitepaperDeveloping AI in software as a medical device (SaMD)
Model and data selection best practices
Read the whitepaperInvesting in Anti-HIV
How HIV therapeutic developers can reshape the future of HIV control
Read the whitepaper
Featured solutions
Blended solutions
Bespoke, seamless solutions to meet unique sponsor challenges.
Outcome Measures
A multi-faceted approach to identifying, selecting, and implementing evidence-based measures that matter to patients.
Biotech
ICON provides full service outsourcing and flexible support for biotech specific needs such as due diligence and asset valuation.
Cardiac Safety Solutions
End-to-end cardiac safety solutions, including ECG, event monitoring, BPM, long-term Holter monitoring, ECHO and MUGA studies.
Early Clinical and Bioanalytical Solutions
Innovative early clinical solutions that will advance your drug development strategy.
Site & Patient Solutions
Transforming recruitment through patient-centric trials and real-world, real-time data.
Market Access
Expertise in mission-critical pricing, market access, and reimbursement.
Specialty Laboratory Solutions
Supporting precision medicine programs across all phases of drug diagnostic co-development.
Webinars
Becoming a sponsor of choice for high-performing sites
3 December 2025. Register now.
Riding the data wave: How pharma can navigate disruptions in open claims
8 December 2025. Register now.
ICH GCP E6(R3): Preparing for global implementation, assessing the impact, risk and requirements of the change
16 December 2025. Register now.